Aasa Shimizu

Exploring the potential of engineered exosomes as delivery systems for tumor-suppressor microRNA replacement therapy in ovarian cancer

Masaki Kobayashi, Kenjiro Sawada, Mayuko Miyamoto et al. · Biochemical and Biophysical Research Communications · 2020 · 107 citations

Pharmacy, Cancer Biology, Oncology +16

Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types

Masaki Kobayashi, Kenjiro Sawada, Koji Nakamura et al. · Journal of Ovarian Research · 2018 · 89 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Exosomal CD47 Plays an Essential Role in Immune Evasion in Ovarian Cancer

Aasa Shimizu, Kenjiro Sawada, Masaki Kobayashi et al. · Molecular Cancer Research · 2021 · 86 citations · Full text

Medicine, Immunology, Oncology +16

Downregulation of miR-194-5p induces paclitaxel resistance in ovarian cancer cells by altering MDM2 expression

Koji Nakamura, Kenjiro Sawada, Mayuko Miyamoto et al. · Oncotarget · 2019 · 40 citations · Full text

Medicine, Oncology, Pharmacology +17

Paclitaxel exposure downregulates miR-522 expression and its downregulation induces paclitaxel resistance in ovarian cancer cells

Mayuko Miyamoto, Kenjiro Sawada, Koji Nakamura et al. · Scientific Reports · 2020 · 20 citations · Full text

Medicine, Oncology, Pharmacology +17